Marijuana Blog

Scientists May Have Discovered A New Species Of Marijuana In Australia

Category: News | Posted on Wed, January, 14th 2015 by THCFinder
new-strain-of-marijuana-possibly-found-in-australiaNew strains of marijuana pop up almost daily anymore. How many of them are actually new strains, versus old strains given a new name for marketing purposes, is tough to say. It’s not everyday that a new species of marijuana is discovered, but that appears to potentially be the case in Australia, where scientists believe they have discovered an entirely new species of marijuana. Per Culture:
Scientists at the University of Sydney believe they have found a fourth species of cannabis. The finding took place in 201 (sic), when a group of people were hiking in the Blue Mountains of Australia and discovered a single plant that resembled cannabis. The shrub was later donated to a research laboratory at the University of Sydney where a series of tests were conducted on the plant – proving that it was indeed cannabis. “When we first received the plant we were very skeptical about its relation to cannabis. It has somewhat similar growth structure, but the leaves look nothing like cannabis leaves,” according to researcher Christopher Pool.
The test results show that the species is resistant to freezing temperatures and the plant grows more like a shrub, without the archetypal candelabra shape of most cannabis strains. Countless cannabis breeders the world over have offered to pay upwards of $2,000 per seed, but Pool stated “The only problem is that we don’t have any seeds, we only have one plant,” adding, “We’ve exhausted our funding trying to find another like it.”
From what it sounds like, we may never get to taste the new strain of marijuana, unless scientists (or seed breeders) can find some more of it. What a tease, right? It begs the question of ‘are there any other species of marijuana out there?’ This is a fantastic development, and is certainly worth monitoring.


White Urkle (Indica)

Category: Nugs | Posted on Wed, January, 14th 2015 by THCFinder


Marijuana Stocks 2015; Invest Or No?

Category: Culture | Posted on Wed, January, 14th 2015 by THCFinder
With so much support of marijuana becoming apparent of the course of the last year, investor optimism in the business has skyrocketed, pushing the marijuana stock companies upwards in value. Marijuana stocks have been some of the top performers of 2014 but it’s questionable whether or not the trends will continue in the new year due to marijuana investors becoming more selective in who they put their money with. 
In 2014, majority of the companies in the marijuana stock business were pink sheets or penny stocks. While it’s definitely an improvement over a severely illegal business, the market is weary of what the new year will hold. Additionally, two companies that trade of the Nasdaq gained an extreme amount of popularity this year; GW Pharmaceuticals and Insys Therapeutics. Both of these companies are developing cannabinoid treatments that will hopefully be used to treat patients with cancer, diabetes, and epilepsy. Since medications like this hold so much potential, these two companies surged in shares by 64% in 2014. 
GW Pharma itself has raised $212 million from their secondary stock offerings in order to fund the development of their medicine, Sativex. This THC based therapy will be used to treat patients suffering from multiple sclerosis can cancer pain. GW Pharma is also working on Epidiolex, a CBD based treatment for epilepsy and like disorders. In Europe, Sativex is already on the market for the treatment of MS but the sales only topped out at $6.8 million in the last twelve months. GW Pharma hopes that by winning the FDA approval in 2015, the amount of sales will go up. The company estimates that the opioid treatment for cancer pain fails to control 20% of what the patients suffer from. 
While both GW Pharma and the company Insys were heavy hitters this year in the stock market but overall, Insys seems to be the one that will pull ahead in 2015. They have a top selling brand on the market, along with a market cap of $1.5 billion, slightly higher than GW Pharma. GW Pharma also has unproven data that needs to be completed before they can get a stamp of approval from the FDA.


Casey Jones (Hybrid)

Category: Nugs | Posted on Tue, January, 13th 2015 by THCFinder


casey-jones-weed-2 casey-jones-weed-4 casey-jones-weed-3

Casey Jones - Hybrid

The Casey Jones flavor is a combination of Oriental Express and the citric sour of the Diesel. The medication can be felt almost immediately. This strain has an effect with a vividly, thought provoking quality. Under its effects, one may feel a stronger sense of connectedness to self and others. It is good for creative activities that can benefit from an introspective mood. Casey Jones also carries Indica properties as well. It is very effective for stress management and joint and muscle pain.


Federal Judge Weighs Marijuana's Classification

Category: News | Posted on Tue, January, 13th 2015 by THCFinder
judge-weighs-mjs-classificationA federal judge in California is weighing the constitutionality of a 45-year-old act that classifies marijuana as a dangerous drug along with LSD, cocaine and heroin.
U.S. District Judge Kimberly J. Mueller in Sacramento held a five-day fact-finding hearing on the classification question late last year, and final arguments are scheduled for next month, the Los Angeles Times reported Monday. Her ruling is expected later this year.
The case marks the first time in decades that a judge has agreed to consider marijuana's designation as a Schedule 1 drug under the 1970 Controlled Substances Act, the newspaper said. Under the act, Schedule 1 drugs have no medicinal purpose, are unsafe even under medical supervision and contain a high potential for abuse.
Mueller's decision to hold the hearing came in response to a pretrial defense motion in a federal case against alleged marijuana growers. Prosecutors unsuccessfully opposed the fact-finding effort.
A ruling against federal cannabis law would apply only to the defendants in the case and almost certainly would be appealed, the newspaper said. If the U.S. 9th Circuit Court of Appeals determined the law was unconstitutional, all the Western states would be affected.
Attorneys for the defendants have argued that the federal marijuana law violates the Constitution's guarantee of equal protection under the law. They contend the government enforces marijuana law unevenly ? allowing distribution of cannabis in states where it is legal and cracking down elsewhere.
The prosecution countered that Congress legally placed pot in Schedule 1.
Zenia K. Gilg, a lawyer for the growers, told the Times that scientific understanding and public acceptance of marijuana have grown substantially since courts last examined the federal classification. She cited the November election, when voters in Alaska and Oregon decided to join Colorado and Washington in making cannabis legal for recreational use. Most states already provide some legal protection for its use as medicine.
Prosecutors said in a brief filed Jan. 7 that the evidence presented in the hearing at most "established that there is some dispute among doctors as to whether marijuana is medicine."


What's packed in your Joint today

Category: Fun | Posted on Tue, January, 13th 2015 by THCFinder




Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
January 30, 2015 | Category: Culture
January 30, 2015 | Category: Nugs
January 30, 2015 | Category: Fun
Mobile Apps
Copyright 2015
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us